16
IRUS TotalDownloads
Altmetric
A novel application of calcium electroporation to cutaneous manifestations of gynaecological cancer
File | Description | Size | Format | |
---|---|---|---|---|
A novel application of calcium electroporation to cutaneous manifestations of gynaecological cancer.pdf | Published version | 2.15 MB | Adobe PDF | View/Open |
Title: | A novel application of calcium electroporation to cutaneous manifestations of gynaecological cancer |
Authors: | Ahmed-Salim, Y Saso, S Meehan, H Galazis, N Phelps, D Jones, B Chan, M Chawla, M Lathouras, K Gabra, H Fotopoulou, C Ghaem-Maghami, S Smith, JR |
Item Type: | Journal Article |
Abstract: | Introduction: Calcium electroporation (CaEP) is a new technique whereby intracellular concentrations of calcium are elevated by transient permeabilisation of the cell membrane using high-voltage electrical pulses. Tumour necrosis is induced with little damage to healthy tissue. Within gynaecological cancer, vulval cancer and vulval intraepithelial neoplasia (VIN) pose challenges for treatment, given the high recurrence rate, persistent symptoms and repeated resections required. In certain cases, CaEP may provide a suitable alternative. Methods: We present a case series of six patients with recurrent vulval squamous cell carcinoma(n=2), VIN III (n=2) and metastatic ovarian cancer (n=2), five of whom were treated with CaEP. This is the first known application of CaEP to gynaecological cancers .Results: The median follow-up time was 14 months (range 2-18 months). Within the cohort of patients, CaEP was applied a total of 10 times, achieving a complete response five times and partial response four times. Symptoms improved within six weeks for eight episodes following CaEP application. Beyond six weeks, symptoms eventually recurred in all patients and four patients required more than one CaEP procedure. CaEP was useful for palliation of distressing symptoms in one case of metastatic ovarian cancer. No intra-operative or post-operative complications have been reported to date. Conclusion: CaEP may be a promising short-term treatment in selected patients with recurrent VIN and vulval cancer, where other treatments had failed. If validated, it could provide an acceptable alternative where surgery is unacceptable. Long term follow-up is required to evaluate effects on recurrence. |
Issue Date: | 15-Aug-2021 |
Date of Acceptance: | 12-Mar-2021 |
URI: | http://hdl.handle.net/10044/1/88613 |
DOI: | 10.31083/j.ejgo4204102 |
ISSN: | 0392-2936 |
Publisher: | Innovative Medical Press |
Start Page: | 662 |
End Page: | 672 |
Journal / Book Title: | European Journal of Gynecological Oncology |
Volume: | 42 |
Issue: | 42 |
Copyright Statement: | ©2021 The Author(s). Published by IMR Press. This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/). |
Sponsor/Funder: | Cancer Research UK Cancer Research UK |
Funder's Grant Number: | WSAA_P84261 16989 |
Keywords: | Science & Technology Life Sciences & Biomedicine Oncology Obstetrics & Gynecology Calcium Electroporation Ovarian cancer Vulval cancer VIN ELECTROCHEMOTHERAPY METASTASES MANAGEMENT 1112 Oncology and Carcinogenesis 1115 Pharmacology and Pharmaceutical Sciences 1116 Medical Physiology Oncology & Carcinogenesis |
Publication Status: | Published |
Online Publication Date: | 2021-08-15 |
Appears in Collections: | Department of Metabolism, Digestion and Reproduction Department of Surgery and Cancer Faculty of Medicine |
This item is licensed under a Creative Commons License